Mean comparison among subjects with or without stroke
At admission
In patients with nonvalvular AF, mean NLR was significantly higher among subjects with stroke compared to individuals without a stroke (5.6 versus 3.1)
499 patients who underwent RFCA for paroxysmal or persistent AF
5.6
At baseline and on day 1 after RFCA
In multivariate analysis, a high post-NLR was an independent predictor for early recurrence after RFCA (HR 1.09; 0.047). Patients with higher NLR (>5.6) had significantly lower AF-free survival on Kaplan-Meier (K-M) curve
2.38 (analysis included mean comparison between groups)
Retrospectively recorded from patient files
The mean NLR was significantly higher in diabetic patients with AF than in those without (mean 2.87 versus 2.2, ). Using a cut-off point of 2.38 NLR was associated with AF (OR 3.486, )
165 patients with paroxysmal AF, who underwent RFCA
3.08 (analysis included mean comparison between groups)
One day prior to ablation
Baseline NLR was high in patients with AF recurrence (mean 3.2 versus 2.5, ). A high baseline NLR (>3.08) was a significant predictor of postablation AF recurrence (HR 1.99, 95% CI 1.33–2.96, )
379 lone AF patients who underwent catheter ablation
5.15 (analysis included mean comparison between groups)
Before and after catheter ablation
The patients who developed AF recurrence had a higher postablation NLR than patients with no recurrence (5.74 versus 4.66, ). A high postablation NLR (>5.15) was an independent predictor of AF recurrence (HR 1.514, 95% CI 1.36–1.68, )
A total of 197 subjects (71 with paroxysmal, 63 with persistent/permanent AF, and 63 AF-free controls)
2.1 (analysis included mean comparison between groups)
At baseline
Higher NLR (>2.1) had a significant relationship with nonvalvular AF (OR 11.31, ) compared with control group; and the mean value was significantly higher in those with persistent/permanent compared to those with paroxysmal AF (3.4 ± 0.6, versus 2.5 ± 0.6, )
A significant positive correlation was observed between NLR and increased interleukin-17 (IL-17A) in AF (). Elevated IL-17A, on the other hand, was significantly increased in patients with AF compared to controls (1.28 ± 3.5 versus 0.19 ± 0.64 pg/mL, )
Median NLR value of the tests performed in the year prior to study entry
Each increase in NLR quartile above the lowest was associated with a significant increase in the risk of stroke with HRs (95% CI) 1.11 (0.91–1.35), 1.25 (1.03–1.51), and 1.56 (1.29–1.88) for the second, third, and highest quartiles, respectively
<6 hours preprocedural, <12, 48, and 96 hours postprocedural
Patients who developed AF (, 13.8%) had higher postcatheterization NLR at 48 hours (median 5.23 versus 3.00, ) and 96 hours (median 4.67 versus 3.56, )
A higher NLR (>4.6) was an independent predictor of NOAF, no-reflow, and in-hospital MACE (OR 3.5, ) in patients with STEMI, after adjustment for confounding factors